buyout

Pep Boys Plummets 22% As Gores Group Pulls Bid, Stifel Issues Negative Comments

pep boys, los angeles, private-equity, philadelphia, california, buyout, the gores group, automotive, u.s. securities, exchange commission, shares, earnings, wall street, business, finance, trading, stock, market, analysis, news

By FNNO Staff
fnnonline@gmail.com

Coty Boosts Avon Bid To $24.75 In Final Buyout Effort

Published on Thu, 05/10/2012 - 09:53
By FNNO Staff in acquisition, analysis, avon, avp, business, buyout, coty, finance, investing, market, news, stock, trading
avp, avon, coty, acquisition, buyout, business, finance, investing, stock, news, trading, analysis, market

By FNNO Staff
fnnonline@gmail.com

Yahoo Willing To Pay $2B for Hulu

Published on Tue, 07/19/2011 - 12:47
By FNNO Staff in General Interest, yhoo, business, buyout, finance, hulu, investing, market, money, news, stock, trading, two million, yahoo, News Update

Yahoo! (NASDAQ:YHOO) has a potential upside of 36.1% based on a current price of $14.49 and an average consensus analyst price target of $19.73.

business, buyout, finance, hulu, investing, market, money, news, stock, trading, two million, yahoo

According to report on Business Insider, Yahoo's (NASDAQ:YHOO) would be willing pay up to $2B to buy Hulu, but only if Hulu's owners, News Corp (NASDAQ:NWSA), Comcast (NASDAQ:CMCSA), Disney (NYSE:DIS) and Providence Equity Partner

By FNNO Staff
fnnonline@gmail.com

Carl Icahn Offers to Acquire Clorox for $76.50 per Share

Published on Fri, 07/15/2011 - 08:05
By FNNO Staff in General Interest, CLX, business, buyout, carl icahn, clorox, finance, investing, market, news, price, share, stock, trading, News Update
business, buyout, carl icahn, clorox, finance, investing, market, news, price, share, stock, trading

Activist Investor Carl Icahn disclosed that on July 14, he sent a letter to Donald Knauss, CEO of Clorox (NYSE:CLX) with a proposal to acquire all of the issued and outstanding shares not owned for $76.50 per share net in cash. Ic

By FNNO Staff
fnnonline@gmail.com

Cephalon rejects Valeant Pharmaceuticals takeover bid

acquisition, bid, buyout, ceph, cephalon, health, m&a, merger, offer, pharma, purchase, reject, share, stock, trade, valeant

Cephalon (CEPH) announced its board formally rejected Valeant Pharmaceuticals International, Inc.'s March 29 unsolicited proposal to purchase the company for $73 per share. Shares of Cephalon are down over 1% to $76.50 in pre-mark

By FNNO Staff
fnnonline@gmail.com

Vivendi to purchase 39% of Activision-Blizzard

acquisition, activision blizzard, buyout, cash, entertainment, gamer, gaming, m&a, media, merger, purchase, stock, vivendi

Rumors are swirling today that French media giant Vivendi may purchase a 39% stake in Activision-Blizzard. Bernstein analysts said repeated stock buy-backs should lift Vivendi’s stake to 72% by early 2012, cash flow would allow

By FNNO Staff
fnnonline@gmail.com

UBS Raises Its Target Price For Calix Inc To $23

The company sees 2011 revenue at $406 million, below the bank's previous estimate of $428 million and well below the consensus estimate for $450 million.

Shares of Calix are trading down 3.48% at $19.71.

acquisition, analyst, bank, buyout, calix, calx, earnings, firm, m&a, merger, nyse, ocnw, price, rating, revenue, share, stock, trade, ubs, wall street

UBS raised its target price for Calix Inc (NYSE:CALX) to $23 from $20 and reiterated its buy rating after the company formally updated its financial outlook for 2011 to include its acquisition of OCNW.

By FNNO Staff
fnnonline@gmail.com

UBS Downgrades Cephalon, Raises Target Price

Published on Thu, 03/31/2011 - 09:45
By FNNO Staff in General Interest, CEPH, ubs, VRX, acquisition, analyst, bank, bid, buyout, ceph, cephalon, m&a, merger, nasdaq, pharma, price, share, stock, trade, ubs, valeant, Analyst Actions

The bank sees some upside to the $73 offer, but not much. Valeant could increase its offer marginally, and there is a reasonable possibility of an additional suitor coming along with a higher bid.

Shares of Cephalon are trading down 0.19% at $75.30.

acquisition, analyst, bank, bid, buyout, ceph, cephalon, m&a, merger, nasdaq, pharma, price, share, stock, trade, ubs, valeant

UBS downgraded Cephalon (NASDAQ:CEPH) to neutral from buy, while raising its target price to $78, after a $73 per share buyout offer from Valeant was made public.

By FNNO Staff
fnnonline@gmail.com

Options Report: March 30, 2011

buyout, ca inc, calls, cephalon, clean energy, debit card, devon energy, financial, genworth, health, investor, kb homes, mastercard, mela sciences, obama, oil, options, pharma, private equity, puts, radioshack, shares, stock market, valeant, visa

On the call side, Cephalon and Valeant Pharmaceuticals calls are trading much higher than normal today, 44.6 and 13.8 times respectively after news that Valeant will acquire Cephalon for $5.7 billion. Genworth Financial calls are

By FNNO Staff
fnnonline@gmail.com

AMR reportedly receives takeout offer, but legitimacy questioned

Published on Wed, 03/30/2011 - 10:49
By FNNO Staff in General Interest, amr, analysis, business, buyout, financial, market, news, sterlong global, stock, trading, News Update
amr, analysis, business, buyout, financial, market, news, sterlong global, stock, trading

Citigroup said AMR reportedly received a $9.75 per share offer last night from Sterling Global Holdings. AMR is currently investigating its legitimacy and if Sterling Global has adequate funding. Citigroup notes that Sterling Glob

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Shares of YRC Worldwide Have Risen Above...

Shares of YRC Worldwide (NASDAQ:YRCW) traded at a new 52-week high today of $30.49. Th ...

Watch for Continued Gains in Shares of T...

Shares of TRW Automotive (NYSE:TRW) traded at a new 52-week high today of $66.79. Appr ...

Shares of Sierra Wireless Rise Above Pre...

Sierra Wireless (NASDAQ:SWIR) traded at a new 52-week high today of $13.03. This new h ...

Seagate Technology: 52-Week High Recentl...

Shares of Seagate Technology (NASDAQ:STX) traded at a new 52-week high today of $45.50. ...

Reinsurance Group of America: The Winnin...

Reinsurance Group of America (NYSE:RGA) traded today at a new 52-week high of $69.15. ...

Targa Resources Partners: 52-Week High R...

Shares of Targa Resources Partners (NASDAQ:NGLS) traded at a new 52-week high today of ...

Recent 52-Week High Exceeded in Shares o...

Shares of Hospira (NYSE:HSP) traded today at $38.50, breaking its 52-week high. Approx ...

Shares of Heartland Payment Systems Rise...

Heartland Payment Systems (NYSE:HPY) traded today at a new 52-week high of $37.17. So ...

Most Popular Video News